RESEARCH-USE BIOSIMILAR ANTIBODY
Naptumomab
Antibody fusion protein · IgG1
Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma.
TARGETTPBG
YAntibody fusion protein
CATALOGSC-BS-352
CATALOG NUMBERSC-BS-352
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATAntibody fusion protein
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma.
Naptumomab is a recombinant research-use antibody directed against TPBG.